1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 220 F.Supp.3d
  5. 220 F.Supp.3d 544 (2016)
 

APTALIS PHARMATECH, INC. v. APOTEX INC.

Civ. No. 14-1038-SLR.

220 F.Supp.3d 544 (2016)

APTALIS PHARMATECH, INC. and Ivax International Gmbh, Plaintiffs, v. APOTEX INC. and Apotex Corp., Defendants.

United States District Court, D. Delaware.

Signed December 8, 2016.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 830 Patent
Source: PACER

Attorney(s) appearing for the Case

Susan Morrison Coletti, Esquire and Robert M. Oakes, Esquire of Fish & Richardson P.C., Wilmington, Delaware. Counsel for Plaintiffs. Of Counsel: Jonathan E. Singer, Esquire and John R. Lane, Esquire of Fish & Richardson P.C.

John C. Phillips, Jr., Esquire and Megan C. Haney, Esquire of Phillips, Goldman, McLaughlin & Hall, P.A., Wilmington, Delaware. Counsel for Defendants. Of Counsel: William R. Zimmerman, Esquire, Craig S. Summers, Esquire, Thomas P. Krzeminski, Esquire, and Karen M. Cassidy, Esquire of Knobbe, Martens, Olson & Bear, LLP.

OPINION

I. INTRODUCTION

This action arises out of the filing of Abbreviated New Drug Application ("ANDA") No. 206703 by defendants Apotex Inc. and Apotex Corp. (collectively "defendants") seeking to produce and market generic versions of AMRIX® ("AMRIX"). (D.I. 1) On August 11, 2014, plaintiffs...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases